U.S. Chemicals Stock News

Entegris (ENTG) has just put fresh numbers on the table, with Q4 2025 revenue of US$823.9 million, basic EPS of US$0.33 and net income of US$49.4 million, setting the tone for its Q1 2026 update. Over the past few quarters, the company has seen revenue move from US$849.8 million in Q4 2024 to US$773.2 million in Q1 2025, then up to US$823.9 million in Q4 2025. Quarterly basic EPS ranged between US$0.33 and US$0.68 over that stretch, giving investors a clear read on how sales and earnings have...

Q1 2026 earnings snapshot Landstar System (LSTR) opened 2026 with Q1 revenue of US$1.2b and EPS of US$1.16, while trailing twelve month revenue stood at US$4.8b and EPS at US$3.62, giving investors a clear read on both the latest quarter and the broader run rate. Over recent quarters, revenue has moved within a tight band between US$1.16b and US$1.22b, while quarterly EPS has ranged from US$0.56 to US$1.31, setting expectations for what kind of profitability the business has been producing as...

In late April 2026, Automatic Data Processing, Inc. reported third-quarter fiscal 2026 results showing year-on-year growth in sales, revenue, net income, and earnings per share from continuing operations. Management linked this performance to wider use of its AI-enabled human capital management tools, which they say is lifting productivity and supporting a higher full-year outlook. Next, we’ll examine how ADP’s AI-driven productivity gains and upgraded fiscal 2026 guidance could influence...

California Water Service Group (CWT) has opened Q1 2026 earnings season with investors looking back at a recent run that saw Q4 2025 revenue at US$220 million and basic EPS of US$0.19, alongside trailing 12 month revenue of about US$1.0 billion and EPS of US$2.15. Over the last few reported quarters, revenue has moved from US$204 million in Q1 2025 to US$311 million in Q3 2025 before landing at US$220 million in Q4, while basic EPS ranged from US$0.22 to just over US$1.02 across the same...

Vistance Networks (VISN) opened 2026 with a mixed tape of numbers, as recent quarters show total revenue moving from US$1,112.2 million in Q1 2025 to US$1,388.1 million in Q2, then US$1,629.7 million in Q3, before a reported loss of US$2,198.4 million in Q4, while basic EPS shifted from US$1.26 to US$0.06, then US$0.40 and finally a loss of US$0.54. Over the trailing twelve months to Q1 2026, basic EPS prints include US$0.03, US$0.42, US$1.34 and US$1.16, reflecting the impact of both...

Qualcomm (NasdaqGS:QCOM) reported record automotive revenue in Q2 2026 and indicated this business is on track to exceed $6b in fiscal 2026. The company disclosed plans to begin shipping custom silicon later this year for a leading hyperscaler data center client, targeting AI workloads. Reports also point to a deeper Qualcomm and OpenAI collaboration on AI focused smartphone chips for a device expected in 2028. For investors who mostly associate Qualcomm with smartphone modems and...

MYR Group (MYRG) has opened 2026 with Q1 revenue of US$1.0b and basic EPS of US$3.01, backed by trailing twelve month EPS of US$9.14 on revenue of US$3.8b and earnings growth reported at about 309.8% over the past year. Over recent quarters, the company has seen revenue move from US$833.6m in Q1 2025 to US$1.0b in Q1 2026, while quarterly basic EPS shifted from US$1.46 to US$3.01 over the same stretch. This sets up a results season in which a 3.7% net margin, along with forecast earnings and...

Trending interest in Sagimet Biosciences (SGMT) centers on its recent acne pipeline update, with plans to file an IND for denifanstat and to move both denifanstat and TVB-3567 into later stage clinical trials. See our latest analysis for Sagimet Biosciences. Those acne trial plans and the recent follow on equity raise come after a sharp run in the shares, with a 30 day share price return of 53.68% and a 1 year total shareholder return of 104.33% from a latest share price of US$8.03. This...

Northeast Community Bancorp (NECB) has just posted another quarter of solid profitability, with Q4 2025 revenue at US$26.8 million and basic EPS at US$0.81, while trailing 12 month figures show revenue of US$104.9 million, net income of US$44.4 million and basic EPS of US$3.35. Over the last few quarters, revenue has ranged from US$24.4 million in Q4 2024 to US$27.5 million in Q3 2024 as quarterly EPS moved between US$0.78 and US$0.97. This sets up a story where investors are watching how a...

Plexus (PLXS) has just posted its Q2 2026 numbers, with revenue of US$1.2b, basic EPS of US$1.86 and net income excluding extra items of US$49.8m setting the tone for the latest update. The company has seen quarterly revenue move from US$980.2m in Q2 2025 to US$1.2b in Q2 2026, while basic EPS has shifted from US$1.44 to US$1.86 over the same period. This gives you a clear view of how the top line and EPS trend across recent quarters feeds into the current release. With trailing twelve month...

Celsius Holdings recently launched ELECTRIC VIBE, a limited-edition Sparkling Tropical Freeze flavor inspired by soccer culture, debuting at the Celsius Soccer Classic in Los Angeles and rolling out across U.S. retail and Canadian channels while supplies last. The product launch anchors a broader soccer-focused push, including the Celsius Soccer Classic charity event and THE SURGE campaign featuring high-profile players and entertainers, signaling how Celsius is tying brand innovation to...

Kymera Therapeutics Q1 2026 earnings snapshot Kymera Therapeutics (KYMR) has kicked off Q1 2026 with the market watching closely after recent quarters that paired modest revenue with sizeable losses, including Q4 2025 revenue of US$2.9 million and a basic EPS loss of US$0.97 on net income excluding extra items of a US$87 million loss. Over the past year, the company has seen quarterly revenue range from US$2.8 million to US$22.1 million, while basic EPS losses moved between US$0.82 and...

If you are wondering whether CVS Health at around US$83.29 is a fair deal or starting to look expensive, the recent share performance gives you a lot to think about. The stock has returned 5.6% over the last 7 days, 16.0% over the past 30 days, 3.9% year to date, 24.3% over 1 year, 36.0% over 3 years and 17.4% over 5 years, which naturally raises questions about how much of this is already reflected in the price. Recent headlines around CVS Health have focused on its position as a large...

Caterpillar Q1 2026 earnings set the stage for mixed margin signals Caterpillar (CAT) has just opened 2026 with Q1 results that sit against a trailing twelve month backdrop of US$67.6b in revenue and US$8.9b in net income, with full year 2025 Q4 revenue at US$19.1b and basic EPS of US$5.15 anchoring the latest reported quarter. Over recent quarters the company has seen revenue move from US$16.2b in Q4 2024 to US$19.1b in Q4 2025, while quarterly basic EPS has ranged from US$4.22 in Q1 2025 to...

Bandwidth (BAND) has opened Q1 2026 earnings season with a recent run of quarterly revenue figures that sit in the low to mid US$100 million range and EPS still in loss making territory, with Q4 2025 revenue at US$207.7 million and basic EPS at a loss of US$0.10, compared with Q4 2024 revenue of US$210.0 million and a loss per share of US$0.06. Over the last year, the company has seen revenue move from US$748.5 million on a trailing basis at Q4 2024 to US$753.8 million at Q4 2025. Over the...

In April 2026, MSA Safety Incorporated introduced its next-generation G1 XR Edition Self-Contained Breathing Apparatus and FireGrid Incident Command API, enhancing firefighter protection with improved comfort, cleaner design, real-time data integration, and compliance with the 2025 NFPA 1970 standard. By tying its G1 SCBA platform into a secure, cloud-based data ecosystem, MSA is pushing firefighter gear toward integrated, software-enabled safety management rather than stand-alone...

If you are trying to work out whether Qfin Holdings at around US$13.08 is a bargain or a value trap, the recent share performance gives you a useful starting point. The stock has seen mixed returns, with a 2.6% gain over the last 7 days and 1.3% over the last 30 days, set against a 31.3% year to date decline and a 64.8% decline over the past year. Those moves sit within a longer track record where 3 year returns are 11.5% lower and 5 year returns are 28.4% lower. This can influence how the...

Wondering if Carnival Corporation & at around US$26.51 is offering real value or just headline excitement? This breakdown will help you connect the recent share price with what the business might be worth. The stock has delivered a 43.0% return over the last year and 183.6% over three years, even though the year-to-date return sits at a 14.3% decline and the last 7 days were roughly flat at a 0.5% fall. Recent attention on the cruise sector has focused on demand recovery, capacity deployment...

This article examines whether Henry Schein, trading at around US$74, is priced fairly or presents a potential mispricing opportunity by breaking down what the current share price might be implying. The stock is up 15.7% over the past year, while the year-to-date return is a 2.9% decline, with a 4.6% drop over the last week and a 1.2% gain over the past month. Recent coverage has focused on Henry Schein as a healthcare supplier navigating changes in demand across dental and medical markets,...

Why Intuitive Machines Stock Is Getting Attention Now Intuitive Machines (LUNR) is back on many watchlists after recent trading left the shares at US$25.35, with the stock showing a mix of positive and negative returns across different recent time frames. See our latest analysis for Intuitive Machines. Recent trading has been choppy, with a 36.6% 1 month share price return and a 41.8% year to date share price return backing up a very large 1 year total shareholder return of 194.1%, suggesting...

Crocs (CROX) has just posted its Q1 2026 results against a backdrop of mixed recent performance, with Q4 2025 revenue at US$957.6 million and basic EPS of US$2.05, alongside trailing twelve month revenue of about US$4.0 billion and a basic EPS loss of US$1.50. Over the last few quarters, the company has seen revenue move from US$989.8 million and EPS of US$6.40 in Q4 2024 to US$937.3 million and EPS of US$2.85 in Q1 2025, then to US$1,149.4 million with a quarterly EPS loss of US$8.82 in Q2...

Cimpress (CMPR) has put fresh numbers on the table for Q3 2026, with recent quarterly revenue running between about US$789 million and US$1.0 billion, while Basic EPS across those periods ranged from a loss of US$1.02 to a profit of US$2.45 per share as net income swung between losses and profits. Over the past few quarters, the company has seen revenue move from US$789.5 million in Q3 2025 to US$1.04 billion in Q2 2026, with EPS shifting from a loss of US$0.33 per share to a gain of US$2.01...

KLA (KLAC) has put another solid quarter on the table, with Q3 2026 revenue of US$3.4b, basic EPS of US$9.17 and trailing twelve month EPS of US$35.52 setting the tone for its latest results. The company has seen revenue move from US$3.1b in Q2 2025 to US$3.4b in Q3 2026, while quarterly EPS has ranged from US$6.18 to US$9.17 over that period. This gives a clear view of how the top line and per share earnings have tracked into this release as margins support the story. See our full analysis...

Scotts Miracle-Gro (SMG) just posted Q2 2026 results with revenue of US$1.5 billion and basic EPS of US$4.53, while trailing 12 month figures show revenue of US$3.5 billion and EPS of US$3.56. Over the past year, revenue has held around the US$3.4 billion to US$3.5 billion mark on a trailing basis, with EPS moving from US$0.69 in the Q2 2025 trailing window to US$3.56 most recently. This sets up this quarter as an important reference point for how earnings are tracking. With net profit...